SARS-CoV-2 SUD2core promotes neutrophil-mediated inflammation by disabling HEBP2-mediated restraint on granule exocytosis
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Ying Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan Unive…. Hauptthemen laut MEDLINE: Neutrophils, Exocytosis, SARS-CoV-2, COVID-19. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan University, West China Hospital, Sichuan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The molecular basis of neutrophil-driven immunopathology in severe coronavirus disease 2019 (COVID-19) remains poorly defined. Here, we identify the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SARS-unique domain (SUD)2core domain as a direct binding partner of the neutrophil-associated protein heme binding protein 2 (HEBP2). We show that HEBP2 normally suppresses azurophilic granule exocytosis, whereas SUD2core recruits the E3 ligase LTN1 to ubiquitinate and degrade HEBP2, thereby activating the Rab27a-Synaptotagmin Like 1 (SYTL1) axis to promote granule release, NETosis, and pro-inflammatory cytokine secretion. In a human immuno-epithelial organoid co-culture model, SUD2core amplifies epithelial damage in an HEBP2-dependent manner. Importantly, two small-molecule compounds that disrupt the SUD2core-HEBP2 interaction effectively attenuate neutrophil-mediated inflammation. These findings reveal a viral strategy that dismantles host restraint on neutrophil effector functions and highlight the SUD2core-HEBP2 interface as a promising therapeutic target for COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China; Institute of Respiratory Health, Targeted Trace…
- Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China.
- Heilongjiang Institute for Drug Control, Harbin, China.
- Department of Cell Biology, Albert Einstein College of Medicine, New York, NY, USA.
Förderung
- Sichuan University
- West China Hospital, Sichuan University
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Shao, S., Lei, Q., Li, C., Yu, Q., Li, Y., Wang, S., Li, L., Chen, H., Huang, R., Deng, H., Li, W., & Wang, C. (2026). SARS-CoV-2 SUD2core promotes neutrophil-mediated inflammation by disabling HEBP2-mediated restraint on granule exocytosis. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117742
Vancouver
Li Y, Shao S, Lei Q, Li C, Yu Q, Li Y, et al. SARS-CoV-2 SUD2core promotes neutrophil-mediated inflammation by disabling HEBP2-mediated restraint on granule exocytosis. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117742
BibTeX
@article{Li2026,
author = {Li, Ying and Shao, Songjun and Lei, Qian and Li, Chunjie and Yu, Quanwei and Li, Yuxiang and Wang, Shui and Li, Lin and Chen, Hai and Huang, Ridong and Deng, Hui and Li, Weimin and Wang, Chengdi},
title = {SARS-CoV-2 SUD2core promotes neutrophil-mediated inflammation by disabling HEBP2-mediated restraint on granule exocytosis},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117742}
}
EUVIMED